# Turnstone Biologics Corp. (TSBX)

Source: https://www.quantisnow.com/company/TSBX
Generated: 2026-11-14T12:37:40.143Z

- Ticker: TSBX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2023

## Latest TSBX news and filings

- 2025-08-21 13:00 UTC [SEC Form 15-12G filed by Turnstone Biologics Corp.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-turnstone-biologics-corp-6174542)
- 2025-08-12 21:22 UTC [SEC Form 4] [SEC Form 4 filed by Director Orbimed Advisors Llc](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-orbimed-advisors-llc-6161415)
- 2025-08-12 20:44 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by Turnstone Biologics Corp.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-turnstone-biologics-corp-6161166)
- 2025-08-12 20:34 UTC [SEC Form 4] [SEC Form 4 filed by Large owner Versant Ventures V, Llc](https://www.quantisnow.com/insight/sec-form-4-filed-by-large-owner-versant-ventures-v-6161080)
- 2025-08-11 20:50 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Turnstone Biologics Corp.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-turnstone-biologics-corp-6158794)
- 2025-08-11 20:48 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Turnstone Biologics Corp.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-turnstone-biologics-corp-6158782)
- 2025-08-11 14:30 UTC [SEC Form 8-K] [Turnstone Biologics Corp. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant](https://www.quantisnow.com/insight/turnstone-biologics-corp-filed-sec-form-8-k-completion-of-acquisition-6157885)
- 2025-08-11 14:04 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Turnstone Biologics Corp.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-turnstone-biologics-corp-6157861)
- 2025-08-11 13:38 UTC [SEC Form 25-NSE filed by Turnstone Biologics Corp.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-turnstone-biologics-corp-6157816)
- 2025-08-11 13:15 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by Turnstone Biologics Corp.](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-turnstone-biologics-corp-6157769)
- 2025-08-11 13:00 UTC [Public Offering] [XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics](https://www.quantisnow.com/insight/xoma-royalty-announces-closing-of-tender-offer-for-turnstone-biologics-6157709)
- 2025-08-08 20:44 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Turnstone Biologics Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-turnstone-biologics-corp-6156706)
- 2025-08-08 20:06 UTC [SEC Form 4] [SEC Form 4 filed by Director Jerel Davis](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-jerel-davis-6156246)
- 2025-08-08 20:05 UTC [SEC Form 4] [SEC Form 4 filed by Director Gupta Rishi](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-gupta-rishi-6156213)
- 2025-07-17 20:37 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Turnstone Biologics Corp.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-turnstone-biologics-corp-6124048)
- 2025-07-17 20:15 UTC [SEC Form 8-K] [Amendment: SEC Form 8-K/A filed by Turnstone Biologics Corp.](https://www.quantisnow.com/insight/amendment-sec-form-8-ka-filed-by-turnstone-biologics-corp-6123851)
- 2025-07-11 11:05 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9 filed by Turnstone Biologics Corp.](https://www.quantisnow.com/insight/sec-form-sc-14d9-filed-by-turnstone-biologics-corp-6117471)
- 2025-07-11 10:05 UTC [SEC Schedule TOT] [SEC Form SC TO-T filed by Turnstone Biologics Corp.](https://www.quantisnow.com/insight/sec-form-sc-to-t-filed-by-turnstone-biologics-corp-6117425)
- 2025-07-01 20:57 UTC [SEC Form 8-K] [Amendment: SEC Form 8-K/A filed by Turnstone Biologics Corp.](https://www.quantisnow.com/insight/amendment-sec-form-8-ka-filed-by-turnstone-biologics-corp-6106386)
- 2025-06-27 20:28 UTC [SEC Form 8-K] [Turnstone Biologics Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure](https://www.quantisnow.com/insight/turnstone-biologics-corp-filed-sec-form-8-k-entry-into-a-6101991)
- 2025-06-27 12:18 UTC [SEC Form SC14D9C filed by Turnstone Biologics Corp.](https://www.quantisnow.com/insight/sec-form-sc14d9c-filed-by-turnstone-biologics-corp-6101384)
- 2025-06-27 12:00 UTC [SEC Form SC TO-C filed by Turnstone Biologics Corp.](https://www.quantisnow.com/insight/sec-form-sc-to-c-filed-by-turnstone-biologics-corp-6101352)
- 2025-06-27 11:30 UTC [Mergers & Acquisitions] [Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right](https://www.quantisnow.com/insight/turnstone-biologics-corp-enters-into-agreement-to-be-acquired-by-6101277)
- 2025-05-12 14:43 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Turnstone Biologics Corp.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-turnstone-biologics-corp-6032328)
- 2025-05-08 22:00 UTC [Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights](https://www.quantisnow.com/insight/turnstone-biologics-corp-reports-first-quarter-2025-financial-results-and-6028668)
- 2025-03-29 01:08 UTC [SEC Form 10-K] [SEC Form 10-K filed by Turnstone Biologics Corp.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-turnstone-biologics-corp-5965690)
- 2025-03-29 01:05 UTC [SEC Form 8-K] [Turnstone Biologics Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/turnstone-biologics-corp-filed-sec-form-8-k-results-of-operations-5965679)
- 2025-03-29 01:03 UTC [Earnings] [Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results](https://www.quantisnow.com/insight/turnstone-biologics-corp-reports-fourth-quarter-and-full-year-2024-5965544)
- 2025-02-05 13:04 UTC [Analyst Downgrade] [Turnstone Biologics downgraded by Piper Sandler with a new price target](https://www.quantisnow.com/insight/turnstone-biologics-downgraded-by-piper-sandler-with-a-new-price-5871936)
- 2025-02-04 14:05 UTC [SEC Form 8-K] [Turnstone Biologics Corp. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/turnstone-biologics-corp-filed-sec-form-8-k-regulation-fd-disclosure-5869160)
- 2025-02-04 14:00 UTC [Turnstone Biologics Announces Plans to Explore Strategic Alternatives](https://www.quantisnow.com/insight/turnstone-biologics-announces-plans-to-explore-strategic-alternatives-5869093)
- 2024-11-15 13:23 UTC [Analyst Downgrade] [Turnstone Biologics downgraded by BofA Securities](https://www.quantisnow.com/insight/turnstone-biologics-downgraded-by-bofa-securities-5778219)
- 2024-11-12 21:20 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Turnstone Biologics Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-turnstone-biologics-corp-5767989)
- 2024-11-12 21:07 UTC [SEC Form 8-K] [Turnstone Biologics Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/turnstone-biologics-corp-filed-sec-form-8-k-results-of-operations-5767552)
- 2024-11-12 21:05 UTC [Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights](https://www.quantisnow.com/insight/turnstone-biologics-corp-reports-third-quarter-2024-financial-results-and-5767345)
- 2024-11-05 14:01 UTC [Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting](https://www.quantisnow.com/insight/turnstone-biologics-presents-preclinical-data-highlighting-potential-for-selected-tumor-infiltrating-5752583)
- 2024-10-14 11:44 UTC [Analyst Downgrade] [Turnstone Biologics downgraded by BofA Securities](https://www.quantisnow.com/insight/turnstone-biologics-downgraded-by-bofa-securities-5724020)
- 2024-10-11 10:15 UTC [SEC Form 8-K] [Turnstone Biologics Corp. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/turnstone-biologics-corp-filed-sec-form-8-k-regulation-fd-disclosure-5722927)
- 2024-10-11 10:00 UTC [Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway](https://www.quantisnow.com/insight/turnstone-biologics-announces-strategic-restructuring-to-prioritize-portfolio-and-extend-5722875)
- 2024-10-01 20:40 UTC [SEC Form 8-K] [Turnstone Biologics Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/turnstone-biologics-corp-filed-sec-form-8-k-notice-of-delisting-5710779)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/TSBX
- Earnings history: https://www.quantisnow.com/earnings/TSBX
- Dividend history: https://www.quantisnow.com/dividends/TSBX
- Insider transactions: https://www.quantisnow.com/insiders/TSBX
- Options chain: https://www.quantisnow.com/options/TSBX
- SEC 8-K filings only: https://www.quantisnow.com/company/TSBX/8-k
- RSS and alerts for TSBX: https://www.quantisnow.com/docs/rss-feeds.md